Found 7 matching trials
Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With Inhibitor PHASE3 Human coagulation factor VII is a vitamin K-dependent serine endogenous pro...
Show More Location
The Second Affiliated Hospital of Chongqing Medical University
Learn More & Join Trial
Treatment of Hemophilia A Patients With FVIII Inhibitors N/A This is a non-interventional, multicenter, observational, international stu...
Show More Location
Arthur M. Blank Hospital
Learn More & Join Trial
Efficacy of Activated Recombinant Human Factor VII in Healthy Volunteers Treated for Punch Biopsy Mediated Bleeding PHASE1 This trial is conducted in the United States of the America (USA). The aim ...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
rhuFVIIa in Post-partum Hemorrhage PHASE4 The aim of this clinical research project is to evaluate the use of the rec...
Show More Location
University Hospital, Lille
Learn More & Join Trial
A Single Dose Trial Investigating Safety and Local Tolerability of Ascending Doses of Long Acting Activated Recombinant Human Factor VII in Healthy Male Volunteers PHASE1 This trial is conducted in Europe. The aim of this clinical trial is to inv...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery PHASE4 This trial is conducted in North America. The aim of this trial is to compa...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial
Safety and Efficacy of 3 Different Doses of Long Acting Factor VII in Haemophilia A or B Patients With Inhibitors PHASE2 This trial is conducted in Asia, Europe, Japan and North America. The aim o...
Show More Location
Novo Nordisk Investigational Site
Learn More & Join Trial